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Interstitial lung disease associated
with collagen vascular disorders: disease
quantification using a computer-aided
diagnosis tool
Abstract The purpose of this study
was to evaluate a computer-aided
diagnosis (CAD) tool compared to
human observers in quantification of
interstitial lung disease (ILD) in pa-
tients with collagen-vascular disor-
ders. A total of 52 patients with
rheumatoid arthritis (n=24), sclero-
derma (n=14) and systemic lupus
erythematosus (n=14) underwent
thin-section CT. Two independent
observers assessed the extent of ILD
(EoILD), reticulation (EoRet) and
ground-glass opacity (EoGGO). CAD
assessed EoILD twice. Pulmonary
function tests were obtained. Statisti-
cal evaluation used 95% limits of
agreement and linear regression anal-
ysis. CAD correlated well with dif-
fusing capacity (DLCO) (R=−0.531,
P<0.0001) and moderately with
forced vital capacity (FVC) (R=
−0.483, P=0.0008). There was close
correlation between CAD and the
readers (EoILD vs. CAD: R=0.716,
P<0.0001; EoRet vs. CAD: R=0.69,
P<0.0001). Subgroup analysis in-
cluding patients with minimal EoGGO
(<15%) strengthened the correlations
between CAD and the readers, readers
and PFT, and CAD and PFT. EoILD
by readers correlated strongly with
DLCO (R=−0.705, P<0.0001) and
moderately with FVC (R=−0.559,
P=0.0002). EoRet correlated closely
with DLCO and moderately with FVC
(DLCO: R=−0.663; FVC: R=−0.436;
P≤0.005). The CAD system is a
promising tool for ILD quantification,
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Introduction
In patients with collagen-vascular disorders (CVD) and
chronic interstitial lung disease (ILD), formal scoring of
disease extent on high-resolution CT (HRCT) has been
shown to improve the accuracy of staging, thereby allowing
selection of high-risk patients who may benefit from
treatment [1]. In patients with scleroderma, for example,
increasingly extensive disease on HRCT proved to be a
strong predictor of mortality [2]. In addition, if combined
with pulmonary function test data, prognostic information
could be obtained in these patients [2]. Furthermore, formal
scoring of disease extent plays an important role in
therapeutic studies in CVD and may also assist in interpre-
tation of patterns of pulmonary function impairment [1].
This illustrates the need for noninvasive and reproducible
scoring systems applicable both to routine clinical practice
and the enrolment of patients in pharmaceutical studies.
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Recently, computer-aided diagnosis (CAD) has been
recognized as a valuable means for improved performance
and decision-making due to enhanced detection and
evaluation of complex imaging features in the chest [3].
The majority of quantitative analysis methods involve the
application of thresholding methods to the segmented
pulmonary parenchyma in order to extract regions with
attenuation values either above or below a user-defined
threshold criterion [3]. This approach may potentially
allow a precise, time-efficient, and reproducible quantifica-
tion of the diseased pulmonary parenchyma, as it requires
only minimal user interaction for definition of a threshold
value [3, 4]. Hence, the aim of this study was to evaluate
the performance of a CAD prototype software for
quantification of disease extent in patients with ILD
associated with CVD and its correlation with physiological
impairment, in comparison with reader-based disease
quantification.
Materials and methods
Patient recruitment and pulmonary function analyses
Data of a retrospective consecutive patient cohort with
known CVD and associated chronic ILD referred for thin-
section CT were investigated. The study was approved by
the institutional ethics committee. Pulmonary function tests
(PFT) were used to measure forced vital capacity (FVC),
forced expiratory volume in 1 s (FEV1), and diffusing
capacity (carbon monoxide transfer factor, DLCO) (Master
Screen Body, Viasys Healthcare, Höchberg/ Germany).
PFTs were performed by using commonly accepted
measurement techniques [8]. Results were expressed as a
percentage of predicted performance derived from pub-
lished standards [5].
CT acquisition and image interpretation
All CTexaminations were acquired with a multidetector-row
CT system (Somatom Sensation 16, Siemens Medical
Solutions, Erlangen/Germany; 120 kV, 55 effective mAs,
0.75-mm slice collimation, 1-mm reconstruction slice
thickness, 1-mm reconstruction increment) at full inspiration
in supine position. CT images were reconstructed by using a
high spatial frequency algorithm (AB 70) and displayed
using lung parenchyma window settings (window level, 500
HU; window width, 1,500 HU).
All the CT images for each patient were indepen-
dently reviewed by two experienced observers who were
blinded to the clinical diagnosis and PFT results. The
observers were asked to score each lobe for the extent of
normal lung and interstitial lung disease (adding up to
100%) to the nearest 5% counting the lingula as a
separate lobe. Interstitial lung disease was subclassified
into reticulation and ground-glass opacification (GGO),
adding up to 100%. If a reticular pattern was reported, the
coarseness of the reticulation was graded on a 3-point scale
(grade 1=intralobular, grade 2=microcystic with cysts 1–
3 mm in size, grade 3=macrocystic with cysts >3 mm in
size). Values for extent of ILD and morphological
parameters were averaged across all lobes.
CT evaluation by the CAD system
The CAD software (MeVisPULMO 3D 3.11, MeVIS
Research, Bremen, Germany) is a prototype system
designed for CT-based automated segmentation of the
airways, lungs, and pulmonary lobes. The algorithm has
been described previously [4] and is characterized by an
initial segmentation of the airways, based on a region-
growing method, that is followed by airway analysis in
order to obtain a graphic representation of the bronchial
tree, including information about direction, diameter, and
length of each branch [6, 7]. The bronchi belonging to each
pulmonary segment are identified automatically.
Based on the bronchial tree, a preliminary mask of the
lung parenchyma is created using a conventional region-
growing method with a fixed threshold interval (−1,024 to
−400 HU) [4]. Subsequently, a marker-based 3D watershed
transform is used that is confined to the area of the
preliminary lung masks in order to obtain separate masks
for each lung [4, 8]. The segmentation of the pulmonary
vasculature is restricted to the area defined by the
previously computed lung masks and is performed using
a conventional 3D region-growing algorithm, thereby
creating a superset of all larger pulmonary vessels.
Accordingly, lobar segmentation is based on the absence
of larger vessels in proximity to the lobar boundaries [8].
For this purpose, a Euclidean distance transform is used,
and lobar areas are obtained from the preprocessed image
using a multidimensional interactive watershed transform
[9]. These region identification steps enable extraction of
various CT parameters [4]. Initially developed for
quantification of pulmonary emphysema, the software
allows extraction of the volume, mean density, pixel index,
bulla index, and emphysema type on a lobar or segmental
basis [4]. Likewise, it is feasible to conduct threshold-based
segmentation of the percentage of areas with interstitial
lung disease, which in this context is defined as an area of
high attenuation. For this purpose, the threshold is defined
by the user. The current prototype software does not correct
for gravity-dependent opacity or overperfusion.
For the current study, all CT images for each patient were
transferred from the CT system to a dedicated storage
workstation (Fujitsu Siemens Celsius, Siemens Medical
Solutions, Erlangen/Germany). Each set of CT images for
each patient was evaluated twice using the MeVisPULMO
3D software by application of a threshold value of −800
HU (Figs. 1, 2 and 3). This threshold value was chosen
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after separate data from a previous patient collective with
ILD had demonstrated an optimum correlation between
the extent of high-attenuation areas and diffusing capacity
(data not shown). As interstitial lung disease tends to be
widespread and, in contrast to emphysema, does not tend
to be confined to single lobes or segments, total extent of
ILD was reported (expressed as percentage areas with high
attenuation, i.e., attenuation above the defined threshold
value).
Fig. 1 A 74-year-old female
patient with rheumatoid arthritis.
Thin-section CT (a, c, e, g)
shows extensive interstitial lung
disease with predominantly
subpleural and basal reticula-
tion, ground-glass opacification
and associated traction bronchi-
ectasis indicating fibrosis. These
areas are precisely segmented
using CAD (b, d, f, h; high-




Data evaluation was performed using the spreadsheet-
based statistical software package StatsDirect (Camcode,
Herts, England, version 2.6.5). Measurement reproduci-
bility of repeated CAD assessments as well as interobserver
agreement between the two study readers was tested using
the method of Bland and Altman, which calculates 95%
limits of agreement between two measurements [10]. This
value is an expression of 95% of all measurements that can
be expected to lie within the calculated (limits of
agreement) range. Mean values of both readers were used
for regression analyses. The relationships among the CAD,
the readers and the PFT results were calculated using linear
Fig. 2 A 53-year-old male pa-
tient with rheumatoid arthritis.
Thin-section CT (a, c) displays
areas of ground-glass opacifica-
tion and associated subpleural
reticulation with a basal predo-
minance. These findings are
depicted as high-attenuation
areas by the CAD application
(b, d)
Fig. 3 A 70-year-old female
patient with systemic lupus er-
ythematosus and known chronic
interstitial lung disease. Thin-




cating fine fibrosis, as well as a
discrete subpleural reticular pat-
tern. CAD enhances visualiza-
tion of the disease extent (b, d)
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regression analysis and Pearson’s product moment corre-
lation. Linear regression parameters were calculated by the
least squares method. Pearson’s product moment correla-
tion coefficient was given as a measure of linear association
between two variables: r ¼
Pn







Calculations were first performed for all 52 patients and
then for a reduced subset of patients with GGO scores
below 15% to evaluate the effect of the amount of GGO on
the correlations among CAD, readers, and PFTs. Further, a
stratum for the three patient diagnoses was introduced
using dummy variables (representing a categorical variable
with more than two levels in the regression model) and
subsequent multiple linear regression analysis to test the
effect of the patient diagnosis on the relationship between
the disease extent as measured by CAD and readers, and
the pulmonary functional impairment as measured by PFTs
[11]. A P value of less than 0.05 was accepted to indicate
statistical significance.
Results
The study group comprised 52 consecutive patients (14
male, 36 female, mean age 59±13 years) with known CVD
and chronic pulmonary disease. Patients had received a
diagnosis of rheumatoid arthritis (RA, n=24), scleroderma
(PSS, n=14), or systemic lupus erythematosus (SLE, n=
14) that met the respective diagnostic criteria of the
American College of Rheumatology [12]. The average
duration of CVD was 10.27±7.04 years in patients with
PSS, 11.25±9.60 years in patients with RA, and 11.0±
6.65 years in patients with SLE. The average duration of
respiratory symptoms was 9.09±7.46 years in patients with
PSS, 3.79±2.57 years in patients with RA, and 6.9±
3.84 years in patients with SLE. None of the patients
reported a history of smoking or smoked at the time of
presentation. Lung biopsies were not performed in any of the
patients. All patients displayed crackles on physical exam-
ination, complained of respiratory symptoms (dyspnea,
cough), and underwent treatment with a steroid or cytotoxic
agent according to various treatment regimens at the time of
CT. At the time of presentation, no patient displayed clinical
or laboratory signs of infection. None of the patients had
overt clinical or echocardiographic evidence of pulmonary
arterial hypertension. The mean time interval between PFTs
and thin-section CTwas 1.5±2.5 days (range: 0–7 days). On
PFT, average DLCO was 58.2±15.1% of predicted, average
FVC was 86.1±23.5% of predicted, and average FEV1 was
87.2±21.0% of predicted.
Measurement reproducibility and interobserver
agreement
There was total concordance between the first and second
measurements of the high-attenuation areas (HAV) by the
CAD tool corresponding to the extent of ILD (95% limits
of agreement=0 to 0, intra-class correlation coefficient=1).
The interobserver agreement of both readers on the extent
of ILD and the various morphological patterns was good
(95% limits of agreement=–27.00 to 17.03%, –24.51 to
15.48%, –32.35 to 20.43%, and –1.10 to 0.82 for extent of
ILD, extent of reticulation, extent of GGO, and coarseness
of reticulation, respectively; intraclass correlation coeffi-
cient=0.89, 0.87, 0.70, and 0.61 for extent of ILD, extent
of reticulation, extent of GGO, and coarseness of reticu-
lation, respectively).
Correlation between CAD results and PFTs
The percentage of high-attenuation areas (average HAV=
25.0±16.9%), corresponding to the extent of ILD by CAD,
showed a significant correlation with DLCO (R=–0.531; 95%
CI=–0.706 to –0.293; P<0.0001) and FVC (R=–0.483;
95% CI=–0.680 to –0.221; P=0.0008), but no significant
correlation with FEV1 (Table 1).
Correlation between reader results and PFTs
On thin-section CT, all patients displayed findings of ILD
(ILD detected by the readers: average extent of ILD=36.3±
27.2%, average extent of reticulation=27.0±23.3%, aver-
age extent of GGO=9.2±17.0%, average coarseness of a
reticular pattern=1.1±0.6%). Major respiratory or cardiac
motion artefacts were not noted in any of the patients.
Average extent of ILD was correlated closely with DLCO
(R=–0.705; 95% CI=–0.831 to –0.511; P<0.0001). There
was a moderate correlation of the average extent of ILD
and FVC (R=–0.559; 95% CI=–0.742 to –0.299; P=
0.0002), and a weak but significant correlation between
the average extent of ILD and FEV1 (R=–0.379; 95% CI=
–0.615 to –0.08; P=0.014). The extent of reticulation
correlated closely with DLCO and moderately with FVC
(DLCO: R=–0.663; 95% CI=–0.805 to –0.449; P<0.0001;
FVC: R=–0.436; 95% CI=–0.658 to –0.144; P=0.005), but
there was no significant correlation between the extent of
reticulation and FEV1 (see Table 1). The extent of GGO did
not show any significant correlation with any of the PFTs
(Table 1). The average coarseness correlated moderately
with DLCO (R=–0.435; 95% CI=–0.653 to –0.151; P=
0.004), but not with FVC or FEV1 (Table 1).
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Correlation between CAD and reader results
There was a close correlation between the extent of ILD
by the readers and CAD (R=0.716; 95% CI=0.529–0.836;
P<0.0001). The extent of reticulation as assessed by the
readers correlated closely with CAD (R=0.69; 95% CI=
0.492–0.821; P<0.0001). The average coarseness as
determined by the readers correlated moderately with
CAD (R=0.508; 95% CI=0.245–0.701; P=0.0005). How-
ever, there was no significant correlation between the
extent of GGO as assessed by the readers and the extent of
ILD by CAD (Table 2).
Correlation between CAD results and PFTs
in a subgroup of patients with minimal
ground-glass opacification
In the 34 patients with minimal GGO, the correlations
between CAD and PFTs were further improved (Table 3).
There were significant correlations between CAD and
DLCO (R=–0.56; 95% CI=–0.758 to –0.269; P=0.0007))
as well as between CAD and FVC (R=–0.521; 95% CI=
–0.728 to –0.228; P=0.001), whereas the correlation
between CAD and FEV1 remained insignificant (Table 3).
Correlation between reader results and PFTs
in a subgroup of patients with minimal ground-glass
opacification
When the analysis was restricted to a patient subgroup of
34 patients with minimal (<15%) GGO, the correlations
between reader results and DLCO were improved (Table 3).
In detail, there were close correlations between the extent
of ILD and DLCO (R=–0.702; 95% CI=–0.842 to –0.472;
P<0.0001) and between the extent of reticulation and
DLCO (R=–0.69; 95% CI=–0.836 to –0.455; P<0.0001),
and a moderate correlation between the average coarseness
and DLCO (R=–0.543; 95% CI=–0.747 to –0.246; P=
0.001). In addition, the correlation between the extent of
reticulation and FVC was improved (R=–0.462; 95%
CI=–0.705 to –0.121; P=0.01).
Table 2 Correlation between reader and CAD results
CAD: HAV
R 95% CI P
Readers Extent of ILD 0.716 0.529 to 0.836 <0.0001*
Extent of reticulation 0.690 0.492 to 0.821 <0.0001*
Extent of ground-glass opacification 0.199 −0.107 to 0.472 0.199
Coarseness 0.508 0.245 to 0.701 0.0005*
Statistically significant correlations marked with an asterisk
R Correlation coefficient, 95% CI confidence interval (Fisher’s z transformed)
Table 1 Correlation between reader/CAD results and PFTs
DLCO FVC FEV1
R 95% CI P R 95% CI P R 95% CI P
CAD Extent of HAV −0.531 −0.706 to
−0.293
<0.0001* −0.483 −0.680 to
−0.221
0.0008* −0.249 −0.498 to
0.038
0.088
Readers Extent of ILD −0.705 −0.831 to
−0.511
<0.0001* −0.559 −0.742 to
−0.299
0.0002* −0.379 −0.615 to
−0.08
0.014*
Extent of reticulation −0.663 −0.805 to
−0.449
<0.0001* −0.436 −0.658 to
−0.144
0.005* −0.241 −0.511 to
0.071
0.128




0.136 −0.304 −0.563 to
0.008
0.056 −0.276 −0.538 to
0.034
0.081
Coarseness −0.435 −0.653 to
−0.151
0.004* −0.191 −0.474 to
−0.128
0.0238 −0.036 −0.340 to
0.274
0.822
Statistically significant correlations marked with an asterisk
R Correlation coefficient, 95% CI confidence interval (Fisher’s z transformed)
329
Correlation between CAD and reader results
in a subgroup of patients with minimal ground-glass
opacification
Restricting the analysis to the subgroup of 34 patients with
minimal GGO also improved the correlations between
reader and CAD results (Table 4). There were close
correlations between the extent of ILD by the readers and
CAD (R=0.779; 95% CI=0.596–0.886; P<0.0001), as
well as between the extent of reticulation and CAD (R=
0.722; 95% CI=0.504–0.854; P<0.0001), and a moderate
correlation between the average coarseness and CAD (R=
0.594; 95% CI=0.314–0.778; P=0.0003).
Effect of patient diagnosis on correlation
between extent of ILD and DLCO
On multivariate linear regression analysis there was no
significant influence of any of the patient diagnoses (RA,
SLE and PSS) on the correlation between the extent of
ILD by CAD and the DLCO [for correlation of extent of
ILD by CAD/disease entity with DLCO: F=18.42; for CAD:
R=–0.508 (95% CI=–0.706 to –0.293, P=0.0003); for the
diagnoses RA, SLE, or PSS: P=0.16–0.22]. Furthermore,
there was no significant influence of any of the patient
diagnoses on the correlation between the extent of ILD by the
readers and the DLCO [for correlation of extent of ILD by
readers/disease entity with DLCO: F=39.62; for readers: R=
–0.701 (95%CI=–0.831 to –0.511,P<0.0001); for diagnoses
RA, SLE, or PSS: P=0.08–0.25]. Moreover, the strength of
the univariate correlation between the extent of ILD by CAD
(Table 1) or by the readers and the DLCO was not reduced
substantially by the disease stratification (P>0.05).
Discussion
Formal scoring of disease extent on HRCT in patients with
ILD associated with CVD has been performed by several
investigators [13–16]. The extent of disease on HRCT has
been found to be inversely correlated to arterial oxygen
levels at rest, and extensive pulmonary fibrosis correlates
with the presence of neutrophilia on bronchoalveolar
lavage [14, 17]. In patients with scleroderma, there is a
close correlation between the extent of disease on HRCT
and diffusing capacity [14]. More recently, a combined
staging system including both disease extent on HRCT
(based on the evaluation of five predefined anatomic
sections scored to the nearest 5%) as well as pulmonary
function test data has been shown to provide discriminatory
prognostic information in these patients [2]. In addition,
formal scoring of disease extent plays an important role in
therapeutic studies in CVD. In a recent study in patients
with scleroderma, the evaluation of disease extent at
Table 4 Correlation between reader/CAD results in subgroup of patients with minimal ground-glass opacification
CAD: HAV
R 95% CI P
Readers Extent of ILD 0.779 0.596–0.886 <0.0001*
Extent of reticulation 0.722 0.504–0.854 <0.0001*
Coarseness 0.594 0.314–0.778 0.0003*
Statistically significant correlations marked with an asterisk
R Correlation coefficient, 95% CI = confidence interval (Fisher’s z transformed)
Table 3 Correlation between reader/CAD results and PFTs in subgroup of patients with minimal ground-glass opacification
DLCO FVC FEV1
R 95% CI P R 95% CI P R 95% CI P
CAD Extent of HAV −0.56 −0.758 to −0.269 0.0007* −0.521 −0.728 to 0.228 0.001* −0.316 −0.574 to −0.001 0.051
Readers Extent of ILD −0.702 −0.842 to −0.473 <0.0001* −0.488 −0.721 to −0.155 0.006* −0.288 −0.583 to 0.073 0.116
Extent of
reticulation
−0.690 −0.836 to −0.455 <0.0001* −0.462 −0.705 to −0.121 0.010* −0.255 −0.559 to 0.109 0.166
Coarseness −0.543 −0.747 to −0.246 0.001* −0.248 −0.558 to 0.123 0.186 −0.062 −0.408 to 0.299 0.74
Statistically significant correlations marked with an asterisk
R Correlation coefficient, 95% CI confidence interval (Fisher’s z transformed)
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baseline strengthened the treatment effect of oral cyclo-
phosphamide against placebo [1, 18]. Furthermore, the
evaluation of disease extent may assist in interpretation of
patterns of pulmonary function impairment. In rheumatoid
arthritis, for example, knowledge of the extent of pulmo-
nary fibrosis may aid in ascribing reduced lung volumes to
interstitial or pleural disease [1].
However, as there are currently no standardized scoring
systems for the assessment of disease extent on thin-section
CT of patients with ILD associated with CVD, the
application of CAD systems offers considerable promise.
Most quantitative analytic methods involve the application
of thresholding methods to the segmented pulmonary
parenchyma in order to extract regions with attenuation
values either above or below a user-defined threshold
criterion [3]. Alternatively, they focus on the generation of
histograms reflecting a regional or global distribution of
pixel attenuations [3]. To date, few studies have investi-
gated the quantitative CAD assessment of ILD in patients
with pulmonary fibrosis using computer-derived histogram
indices, showing correlation between different histogram
features and physiologic impairment [19–22]. In addition,
attempts have been made to better quantify complex lung
patterns by application of texture analysis using measure-
ments such as entropy, or by using the “Adaptive Multiple
Feature Method” which identifies normal lung as well as
different patterns of infiltrative lung disease [3, 23].
The prototypical software application MeVisPULMO
used in our study was designed to assist the radiologist in
functional analysis of thoracic CT data. It allows extraction
of volumes and CT parameters such as mean attenuation,
percentage of high or low attenuation areas, or pixel index
on a lobar level [4]. Preliminary studies using the CAD
system in patients undergoing lung volume reduction
surgery showed that the CT-based prediction of FEV1
correlated significantly with perfusion scintigraphy results
[4]. However, the MeVisPULMO software was not
evaluated in quantification of ILD.
In our study, the percentage of segmented lung by CAD
correlated significantly with the extent of ILD as evaluated
by the readers and further with morphologic parameters
including the extent of reticulation and the degree of
coarseness (Figs. 1, 2). Although the correlation of extent
of ILD by CAD with diffusing capacity was slightly weaker
than that between diffusing capacity and the extent of ILD by
the readers, the CAD-functional correlation is comparable
with the results of human observers in other studies [16, 24].
In concordance with the readers, the CAD result closely
correlated with DLCO and the FVC. Diffusing capacity
reflected the extent of ILD on CT more accurately than the
other PFTs, which is in keepingwith the results ofWells et al.
in patients with systemic sclerosis [14]. Notably, the results
of the multivariate analyses in our study showed that these
relationships were independent of the disease entity in the
individual cases, indicating a robust performance of the CAD
tool in this heterogeneous patient cohort.
The scoring system used in our study was based on lobar
assessment of total disease extent, reticulation, GGO and
coarseness (modified after ref. [25]). We observed good
correlations between the extent of ILD as well as the extent
of reticulation and the DLCO or FVC. The lack of
correlation between the extent of GGO and DLCO is likely
to be partly due to the limited extent of this pattern in the
study group. However, the correlations between CAD and
readers (extent of disease, extent of reticulation, coarse-
ness) and PFTs (DLCO, FVC) were strengthened when the
analyses were restricted to patients with minimal GGO
(<15%). In collagen-vascular disorders, GGO may reflect
inhomogeneous lung ventilation or perfusion as well as
infiltrative (e.g., infectious) disease or drug toxicity [16,
26, 27]. GGO mixed with a reticular pattern is indicative of
fine fibrosis below the spatial resolution of thin-section CT,
particularly if traction bronchiolectasis is present within
these areas (Fig. 3) [26]. The diversity of causes of GGO
may have contributed to the weak relationships between
CAD and PFTs, CAD and the readers, as well as between
the readers and PFTs in patients with extensive GGO.
A number of potential limitations of our study need to be
considered. Firstly, our study focused on quantification of
total disease extent, and no pattern-based analysis of the
CT examinations was performed. However, the disease
extent was concordantly shown in this and in previous
series to be a strong predictor of functional pulmonary
impairment and therefore the stage of pulmonary disease,
which is an important prerequisite for evaluation of a CAD
tool [13, 14]. An issue that needs consideration for
optimization of the CAD tool is the overlap of attenuation
values of ILD and pulmonary vasculature, leading to
inclusion of small pulmonary vessels, which are likely to
have resulted in an overestimation of disease extent.
Furthermore, the quantification of disease extent using
CAD was limited to high-attenuation areas. Thus, its
performance is based on a density dichotomy between the
normal parenchyma and fibrotic lung areas, disregarding
areas of low attenuation potentially reflecting a bronchio-
litic component. However, CAD quantification of small-
airways disease associated with CVD would strongly
depend on the use of expiratory CT examinations, which
were not available in our patient cohort. The CAD system
used does not allow differentiation of reticular and
amorphous elements of increased attenuation, which
represents a practical limitation, as does the inclusion of
relatively overperfused areas in subjects with coexisting
small-airways disease, as well as the lack of correction for
gravity-dependent opacities. Finally, CAD evaluation did
not focus on anatomic compartments of the lung; however,
in contrast to emphysema, ILD tends to be widespread and
both morphologically and functionally usually does not
reflect a lobar distribution pattern. Formal HRCT scoring,
particularly in pharmaceutical trials, is commonly per-
formed using predefined anatomic levels rather than
pulmonary lobes, as discontinuous HRCT examinations
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(as opposed to volumetric multidetector-row CT examina-
tions) are still widely performed for reasons of radiation
protection. The use of CAD in the evaluation of single
interspaced thin sections should therefore be subject to
further investigation.
In conclusion, the CAD application used proved to be
time-efficient, requiring a mean evaluation time of less than
5 min, and to be well reproducible to aid in significantly
reducing interobserver variability. It holds promise to
become a valuable tool for quantification of interstitial lung
disease, showing close correlation with human observers
and physiologic impairment. These observations should be
confirmed in future studies enrolling larger cohorts of
patients with ILD.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which
permits any noncommercial use, distribution, and reproduction in
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